Title:
マラリアの予防又は治療に有用なトリアミノピリミジン化合物
Document Type and Number:
Japanese Patent JP6529983
Kind Code:
B2
Abstract:
The present invention relates to triaminopyrimidines and to pharmaceutically acceptable salts thereof, to their use in the treatment and/or prevention of malaria caused by plasmodium species, and to their methods of preparation.
Inventors:
Hammed Pier Mohammed, Shuffle
Patil, Vicas
Morgan, Canaan
Visa-Le Lao Belal, Equnus
Ray Turkal, Anankumar
Lanji, Sudir
Putter, Jaya Shree
Roy Chowdhury, Niranjana
Shambuhag, Gagernan
Corsic, Krishna
Ayar, Pravin
Kartika Sambanda Marcy, Vasan
Solar pull, thresh
Narayanan, Shridar
Patil, Vicas
Morgan, Canaan
Visa-Le Lao Belal, Equnus
Ray Turkal, Anankumar
Lanji, Sudir
Putter, Jaya Shree
Roy Chowdhury, Niranjana
Shambuhag, Gagernan
Corsic, Krishna
Ayar, Pravin
Kartika Sambanda Marcy, Vasan
Solar pull, thresh
Narayanan, Shridar
Application Number:
JP2016562579A
Publication Date:
June 12, 2019
Filing Date:
March 26, 2015
Export Citation:
Assignee:
MM Medicins for Malaria Venture
International Classes:
C07D401/14; A61K31/506; A61K45/00; A61P33/06
Foreign References:
| US20090048250 |
Other References:
DENG,X. et al,Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials,Bioorganic & Medicinal Chemistry Letters,2010年 6月 2日,Vol.20, No.14,p.4027-4031
Attorney, Agent or Firm:
Masayoshi Suda
Akira Murasawa
Akira Murasawa